Search

Your search keyword '"Chiu, C-H."' showing total 760 results

Search Constraints

Start Over You searched for: Author "Chiu, C-H." Remove constraint Author: "Chiu, C-H."
760 results on '"Chiu, C-H."'

Search Results

8. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

9. The Effects of Computerized Inquiry-Stage-Dependent Argumentation Assistance on Elementary Students' Science Process and Argument Construction Skills

12. OA01.07 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations

22. 264P Updated analysis of entrectinib in a subset of Chinese (mainland China, Hong Kong, Taiwan) patients (pts) with NTRK fusion-positive (fp) solid tumours and ROS1-fp non-small cell lung cancer (NSCLC)

23. LBA8 Nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) with disease progression after EGFR tyrosine kinase inhibitors (TKIs) in CheckMate 722

24. MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis

25. EP08.02-029 Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment

30. 110P Updated efficacy and safety of entrectinib in patients (pts) with NTRK fusion-positive (NTRK-fp) NSCLC

31. 111P Entrectinib in Chinese (mainland China, Hong Kong, Taiwan) patients (pts) with locally advanced/metastatic ROS1 fusion-positive (fp) NSCLC and NTRK-fp solid tumours

33. Elementary Students' Participation Style in Synchronous Online Communication and Collaboration

34. The Development of SCORM-Conformant Learning Content Based on the Learning Cycle Using Participatory Design

37. Directional growth effect on magneto-mechanical properties of Fe81Al19 alloy.

38. High-coercivity heavy-rare-earth-free NdFeB sintered magnets developed by doping Ce85Al15 and grain boundary diffusion with Pr70Cu15Al15.

39. Evaluating System-Based Strategies for Managing Conflict in Collaborative Concept Mapping

49. 1197P First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Asian subgroup analysis of CROWN

50. 1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)

Catalog

Books, media, physical & digital resources